Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayapal Reddy Mallareddy

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Elife|July 8, 2024
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentationNicholas J Mullen, Surendra K Shukla, Ravi Thakur, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentationNicholas J Mullen, Surendra K Shukla, Ravi Thakur, et al.
Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.
RSC Advances|April 4, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growthJohn Victor Napoleon, Satish Sagar, Sydney P Kubica, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Elife|July 8, 2024
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentationNicholas J Mullen, Surendra K Shukla, Ravi Thakur, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentationNicholas J Mullen, Surendra K Shukla, Ravi Thakur, et al.
Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.
RSC Advances|April 4, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growthJohn Victor Napoleon, Satish Sagar, Sydney P Kubica, et al.
Pageof 3